Company Filing History:
1 out of 263 
1 out of 15,475 
1 out of 2 Years Active: 2019-2020
Title: Inventor Kin Sing Stephen Lee: Pioneering Research in Lipid Metabolites and Inflammation Treatment
Introduction: Kin Sing Stephen Lee is a distinguished inventor based in Davis, California, known for his impactful contributions to the field of pharmaceutical research and development. With a total of two patents to his name, he has focused on creating innovative solutions that address inflammation and other related disorders.
Latest Patents: Stephen Lee's most recent patents revolve around stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase (sEH). His research provides methods to reduce inflammation, angiogenesis, vascular leakage, and neovascularization by administering stable analogs of these metabolites alongside sEH inhibitors. Moreover, he has developed pharmaceutical compositions and kits containing these stable analogs and inhibitors to treat disorders connected with inflammation. Another significant invention of his consists of a new series of sEH inhibitors that boast improved properties, enhancing their druglikeness for treating conditions such as chronic diabetic neuropathic pain.
Career Highlights: Throughout his career, Kin Sing Stephen Lee has made notable strides in medical research, particularly during his tenure at prestigious institutions like the Massachusetts Eye and Ear Infirmary and the University of California. His work has garnered attention for its potential applications in clinical settings, particularly in addressing life-altering diseases.
Collaborations: Stephen Lee has collaborated with several esteemed professionals in the field, including Bruce D. Hammock and Kip M. Connor. These partnerships have fostered innovative research, leading to advancements in therapeutic solutions targeting inflammatory diseases.
Conclusion: As an inventor, Kin Sing Stephen Lee exemplifies dedication and ingenuity in the field of pharmaceutical research. His patents reflect a commitment to developing groundbreaking treatments for inflammation-related disorders, making significant contributions to an area of research that has critical implications for public health.